Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
Benign prostatic hyperplasia is a common disease in men aged over 50 years old, with an incidence increasing to more than 80% over the age of 70, that is increasingly going to attract pharmaceutical interest. Within conventional therapies, such as α-adrenoreceptor antagonists and 5α-reductase inhibi...
Main Authors: | Paolo Governa, Daniela Giachetti, Marco Biagi, Fabrizio Manetti, Luca De Vico |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2016-11-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/2698.pdf |
Similar Items
-
Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia
by: Daniela Buonocore, et al.
Published: (2018-09-01) -
Serenoa repens: Does it have any role in the management of androgenetic alopecia?
by: Murugusundram Sundaram
Published: (2009-01-01) -
Telogen effluvium treated with Serenoa repens supplement
by: Michele Pezza, et al.
Published: (2014-03-01) -
Fast design of arbitrary length loops in proteins using InteractiveRosetta
by: William F. Hooper, et al.
Published: (2018-09-01) -
Lipidosterolic Extract of Serenoa Repens Modulates the Expression of Inflammation Related-Genes in Benign Prostatic Hyperplasia Epithelial and Stromal Cells
by: Stéphane Terry, et al.
Published: (2013-07-01)